Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market Size By Type (Dry PCR, Fluorescence PCR), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market was valued at USD 213.5 million in 2023 and is projected to surpass USD 418.2 million by 2031, expanding at a CAGR of 8.7% during the forecast period from 2023 to 2031. This growth is fueled by the rising prevalence of foodborne infections, increasing awareness about early pathogen detection, and technological advancements in nucleic acid amplification and detection methods. These kits provide rapid and highly specific diagnostics, significantly aiding clinical diagnostics and public health monitoring, especially in regions facing outbreaks of Plesiomonas-related gastroenteritis.

Drivers:

1. Rising Incidence of Waterborne and Foodborne Infections:

Plesiomonas shigelloides is commonly associated with waterborne and foodborne illnesses, particularly in developing countries. The increased occurrence of such infections is driving demand for rapid and accurate diagnostic solutions.

2. Technological Advancements in Molecular Diagnostics:

Progress in nucleic acid detection technologies—such as real-time PCR, loop-mediated isothermal amplification (LAMP), and CRISPR-based diagnostics—is enhancing the accuracy, speed, and sensitivity of pathogen detection.

3. Growing Demand for Point-of-Care Testing (POCT):

Portable and user-friendly nucleic acid detection kits are gaining popularity in clinical and remote settings, supporting timely diagnosis and improved patient outcomes.

Restraints:

1. Limited Awareness and Surveillance in Low-Income Regions:

Despite the benefits of early detection, several low-income regions lack proper surveillance infrastructure and awareness about the disease, which limits market penetration.

2. High Cost of Advanced Detection Technologies:

The cost of nucleic acid-based testing kits remains a barrier, especially in resource-limited healthcare settings. Cost-intensive reagents and devices limit their widespread adoption in budget-constrained systems.

Opportunity:

1. Expansion in Emerging Economies:

Emerging markets in Asia-Pacific and Africa are witnessing increased investments in healthcare infrastructure, offering potential for diagnostics market growth, especially in areas prone to bacterial outbreaks.

2. Development of Multiplex Diagnostic Kits:

The demand for multiplex kits capable of simultaneously detecting multiple pathogens, including Plesiomonas, is opening new revenue streams for diagnostic manufacturers.

Market by System Type Insights:

Based on system type, the Real-Time PCR Kits segment dominated the market in 2023 due to its established application in clinical diagnostics, high sensitivity, and quick turnaround times. However, the Isothermal Amplification Kits segment is anticipated to witness the fastest growth, attributed to its ease of use, minimal equipment requirement, and suitability for decentralized settings.

Market by End-Use Insights:

The Hospital Laboratories segment emerged as the largest end-user in 2023, driven by increasing hospital admissions for gastroenteritis and the need for accurate, rapid diagnosis. Public Health Labs are expected to grow at a notable pace, fueled by surveillance programs and governmental initiatives to contain disease outbreaks through early pathogen identification.

Market by Regional Insights:

North America led the market in 2023, supported by a strong public health infrastructure, high adoption of advanced molecular diagnostics, and robust regulatory frameworks. Asia-Pacific is projected to grow at the fastest rate, owing to the high prevalence of waterborne infections and expanding diagnostic capabilities in China, India, and Southeast Asia.

Competitive Scenario:

Key players in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Seegene Inc., and GenScript Biotech Corporation. Companies are investing in R&D for multiplex panel development, expanding their product portfolios, and engaging in collaborations with healthcare institutions and governmental health agencies.

Key Developments:

In 2023, QIAGEN launched a new multiplex PCR panel capable of detecting Plesiomonas shigelloides along with other gastrointestinal pathogens.

In 2024, Seegene announced AI-powered assay design capabilities for faster adaptation of nucleic acid tests to emerging strains.

In 2025, Roche Diagnostics received regulatory approval for its point-of-care molecular test targeting enteric pathogens, including Plesiomonas.

Scope of Work – Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market

Report Metric Details

Market Size (2023) USD 213.5 million

Projected Market Size (2031) USD 418.2 million

CAGR (2023–2031) 8.7%

Market Segments System Type (Real-Time PCR Kits, Isothermal Kits), End-Use (Hospital Labs, Public Health Labs, Academic Research)

Growth Drivers Rising prevalence of waterborne infections, adoption of POCT, advancement in molecular diagnostics

Opportunities Multiplex assay development, market expansion in emerging economies

FAQs:

What is the current market size of the Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market?

The market was valued at USD 213.5 million in 2023.

What is the major growth driver of the Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market?

The rising incidence of foodborne infections and technological advancements in nucleic acid testing are the primary growth drivers.

Which is the largest region during the forecast period in the Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market?

North America dominated the market in 2023, but Asia-Pacific is expected to grow the fastest.

Which segment accounted for the largest market share in Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market?

Real-Time PCR Kits held the largest market share in 2023.

Who are the key market players in the Global Plesiomonas Shigelloides Nucleic Acid Detection Kit Market?

Key players include Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Roche, Abbott, Seegene, and GenScript.